Thrive Wealth Management’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$263K Buy
6,506
+95
+1% +$4.25K 0.03% 217
2026
Q2
$299K Sell
6,411
-48
-0.7% -$2.22K 0.04% 193
2026
Q1
$317K Buy
6,459
+111
+2% +$5.16K 0.05% 174
2025
Q4
$277K Buy
6,348
+1,759
+38% +$80.3K 0.04% 191
2025
Q3
$207K Buy
+4,589
New +$202K 0.03% 229
2025
Q2
– Sell
-4,541
Closed -$209K – 233
2025
Q1
$209K Buy
+4,541
New +$190K 0.04% 209
2022
Q1
– Sell
-5,804
Closed -$239K – 158
2021
Q4
$239K Buy
+5,804
New +$219K 0.08% 131

Other funds holding EXC

Thrive Wealth Management's EXC Position: Q3 2026 in Review

Thrive Wealth Management increased its Exelon (EXC) stake by 1.5% in Q3 2026, buying an estimated $4.25K and bringing the position to 6,506 shares worth $263K. The position accounts for 0.03% of the portfolio, ranked #217.

Thrive Wealth Management first reported a position in EXC in Q4 2021 and has held it in 7 quarters since. The position peaked at $317K in Q1 2026. 178 funds tracked by Wall St. Rank hold EXC as of Q3 2026.

  • Thrive Wealth Management held 6,506 shares of Exelon worth $263K as of Q3 2026.
  • Thrive Wealth Management bought 95 Exelon shares in Q3 2026, an estimated $4.25K.
  • Exelon made up 0.03% of Thrive Wealth Management's portfolio in Q3 2026, its #217 holding.
  • Thrive Wealth Management first reported a position in Exelon in Q4 2021 and has held it in 7 quarters since.
  • Thrive Wealth Management's Exelon position peaked at $317K in Q1 2026.
  • 178 funds tracked by Wall St. Rank held Exelon as of Q3 2026.

Based on Thrive Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.